{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-189064","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2022-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.225310+00:00","generated_at":"2026-06-24T19:37:48.479071+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Guardant Health appoints Steve E. Krognes to board of directors","bullets":["Appointed as Class III director effective June 30, 2022, term expiring at 2024 annual meeting.","Will serve as audit committee chair and on the nominating and corporate governance committee.","Krognes previously CFO of Denali Therapeutics and Genentech; over 20 years biotech/life sciences.","Will receive standard non-employee director compensation: stock option and RSU each valued at $362,500.","Also enters into standard indemnification agreement with the Company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-189064","json":"https://secwatch.observer/filing/0001193125-22-189064.json","markdown":"https://secwatch.observer/filing/0001193125-22-189064.md","text":"https://secwatch.observer/filing/0001193125-22-189064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/0001193125-22-189064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/d288735d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T19:37:48.479071+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f28d1ca7d","claim":"Steve E. Krognes was appointed as Class III director at Guardant Health, Inc..","evidence_excerpt":"Effective June 30, 2022, the Board of Directors (the “ Board ”) of Guardant Health, Inc. (the “ Company ”) increased the number of directors on the Board to eight and appointed Steve E. Krognes as a Class III director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/0001193125-22-189064-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}